Asensus Surgical Inc [ASXC] stock is trading at $0.24, up 5.37%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ASXC shares have gain 12.19% over the last week, with a monthly amount drifted -2.48%, and not seem to be holding up well over a long-time horizon.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
On 14, November 2023, Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023. In a post published today on Yahoo Finance, Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2023.
From an analyst’s perspective:
Asensus Surgical Inc [AMEX: ASXC] stock has seen the most recent analyst activity on November 16, 2023, when Cantor Fitzgerald downgraded its rating to a Neutral.
Asensus Surgical Inc [ASXC] stock has fluctuated between $0.20 and $1.18 over the past year. Currently, Wall Street analysts expect the stock to reach $2.00 within the next 12 months. Asensus Surgical Inc [AMEX: ASXC] shares were valued at $0.24 at the most recent close of the market. An investor can expect a potential return of 733.33% based on the average ASXC price forecast.
Analyzing the ASXC fundamentals
Asensus Surgical Inc [AMEX:ASXC] reported sales of 1.09 billion for the most recent quarter, which represents a drop of -57.51%. A company’s income per employee is -$383,558 while it generates $35,975 in revenue per employee. Gross Margin for this corporation currently stands at -162.17% with Operating Margin at -1063.40%, Pretax Margin comes in at -1061.70%, and Net Margin reading is -1066.19%. To continue investigating profitability, this company’s Return on Assets is posted at -49.22, Equity is -56.20, Total Capital is -53.81, and Invested Capital is -54.24. An extended look at the Principal structure reveals enduring liabilities to the total capital of 5.27 and enduring liabilities to assets of 4.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2224 points at the first support level, and at 0.2093 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.2443, and for the 2nd resistance point, it is at 0.2531.
Asensus Surgical Inc [ASXC] reported earnings per share of -$0.07 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.07/share, meaning a difference of $0 and a surprise factor of 0.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.09 per share as compared to estimates of -$0.08 per share, a difference of -$0.01 representing a surprise of -12.50%.
Ratios To Look Out For
For context, Asensus Surgical Inc’s Current Ratio is 3.79. As well, the Quick Ratio is 7.55, while the Cash Ratio is 6.77. Considering the valuation of this stock, the price to sales ratio is 11.58, the price to book ratio is 0.83.
Transactions by insiders
Recent insider trading involved Biffi Andrea, Director, that happened on Mar 03 when 0.29 million shares were purchased.